(MGTA) – Management Comments
-
Magenta Therapeutics (MGTA) Announces IND Clearance for MGTA-117 Targeted Conditioning Clinical Trial
-
Magenta Therapeutics (MGTA) Highlights Final Phase 1 Results of MGTA-145 Stem Cell Mobilization Clinical Trial and Preclinical Data from Targeted Conditioning Program at EBMT 2021 Meetings
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to MGTA Stock Lookup